Boundary checkEU

MDR vs GPSR Medical-device boundary checks

Use MDR first when the product has a medical purpose, is an accessory to a medical device, or falls into an Annex XVI non-medical product group once common specifications apply.

GPSR-specific article duties are not available in this MDR grounding set, so this page treats general product safety cautiously as a fallback question for products or risks not covered by the medical-device regime.

Back to main artifactReview sources
Author
Sorena AI
Published
May 9, 2026
Updated
May 9, 2026
Sections
3

Structured answer sets in this page tree.

Primary sources
5

Cited legal and guidance references.

Publication metadata
Sorena AI
Published May 9, 2026
Updated May 9, 2026
Overview

The practical question is not whether a product can be labelled MDR or GPSR in isolation. Start with the product's intended purpose, claims, user population, body contact, software function, accessory relationship, and Annex XVI status. If those facts do not put the product under MDR, or if a hazard sits outside the MDR file, then treat general product safety as a separate fallback analysis rather than reusing the MDR conclusion.

Side-by-side comparison

MDR vs GPSR: cautious boundary comparison

A grounded comparison for deciding whether a product belongs in the MDR file, Annex XVI work, or a separate general product-safety review. GPSR-specific article duties are not stated because the MDR grounding folder does not contain a GPSR source.

Review all sources
First framework
MDR

Use MDR for medical devices, accessories, intended-purpose classification, conformity assessment, technical documentation, clinical evidence, PMS, vigilance, UDI, and EUDAMED.

Second framework
GPSR / general product safety

Use this side only as a cautious fallback prompt: if the product or hazard is not covered by MDR, confirm the current general product-safety regime from a GPSR source before assigning duties.

Comparison row 1

Scope boundary

MDR

Does the product have a medical intended purpose, act as an accessory, or otherwise fall within Regulation (EU) 2017/745?

GPSR / general product safety

Is the product a consumer product placed or made available on the market, with risks that are not already covered by MDR, so a GPSR review is needed?

Operational implication

Do not use GPSR as a shortcut around MDR. Qualify the product under MDR first, then document what remains outside the medical-device file.

Comparison row 2

Covered actors

MDR

MDR analysis starts with intended purpose, medical claims, software outputs, IFU statements, accessory use, and user population.

GPSR / general product safety

GPSR analysis starts with the product's consumer safety characteristics, its presentation, and whether the product is safe for consumers in normal and foreseeable use.

Operational implication

Preserve claim evidence with the scope decision because a marketing or IFU change can change the regulatory route.

Comparison row 3

Trigger

MDR

Annex XVI can bring listed non-medical products into MDR-style controls when common specifications apply.

GPSR / general product safety

GPSR is triggered when a consumer product is outside sector-specific rules or when a covered product has risks that are not addressed by those rules.

Operational implication

Beauty, wellness, body-modification, skin-treatment, and similar products need a documented Annex XVI screen before the GPSR side is considered complete.

Comparison row 4

Core obligations

MDR

MDR evidence should include qualification rationale, classification rule, technical documentation, clinical evaluation, PMS or PMCF where relevant, vigilance procedures, UDI data, and EUDAMED records.

GPSR / general product safety

GPSR evidence should include internal risk analysis, technical documentation, traceability, contact details, instructions and safety information, and recall or accident-response records.

Operational implication

Use a shared evidence index only if each record is tagged to the regime and claim it actually supports.

Comparison row 5

Evidence record

MDR

MDR devices need PMS and vigilance routing, including serious-incident and field safety corrective action assessment.

GPSR / general product safety

GPSR issues should route to the Safety Business Gateway, consumer warnings, recall notices, and market-surveillance notifications.

Operational implication

Incident intake should ask whether the product is an MDR device, an Annex XVI product, a dual-purpose product, or outside the MDR file.

Comparison row 6

Timing and deadlines

MDR

If a medical purpose, accessory relationship, classification rule, Annex XVI category, or MDR PMS/vigilance trigger is present, keep the issue in the MDR workstream.

GPSR / general product safety

If none of those MDR anchors applies, treat the matter as a separate general product-safety question and verify current GPSR duties from a GPSR source before acting.

Operational implication

The useful output is a short scope record: product facts, claims reviewed, MDR conclusion, Annex XVI conclusion, open GPSR-source gap, owner, and next review trigger.

Comparison row 7

Enforcement

MDR

MDR enforcement focuses on conformity assessment, vigilance, post-market surveillance, and market surveillance for devices in MDR scope.

GPSR / general product safety

GPSR enforcement focuses on dangerous consumer products, market surveillance, Safety Gate notifications, and recall handling.

Operational implication

Do not use GPSR as a shortcut around MDR. Qualify the product under MDR first, then document what remains outside the medical-device file.

Comparison row 8

Overlap and reuse

MDR

MDR and GPSR can overlap on a product's non-medical risks, but MDR remains the first check when the intended purpose is medical or the product is an accessory or Annex XVI product.

GPSR / general product safety

GPSR handles the safety gaps that remain after sector-specific legislation has been checked, including products that are outside MDR scope.

Operational implication

Do not use GPSR as a shortcut around MDR. Qualify the product under MDR first, then document what remains outside the medical-device file.

Comparison row 9

Practical decision rule

MDR

Does the product have a medical intended purpose, act as an accessory, or otherwise fall within Regulation (EU) 2017/745?

GPSR / general product safety

If not, does the product fall within the consumer-product safety regime and need a GPSR source check for the remaining risks?

Operational implication

Do not use GPSR as a shortcut around MDR. Qualify the product under MDR first, then document what remains outside the medical-device file.

Practical decision rule

Practical decision rule

  • Use MDR when the facts match the left-side scope, trigger, and evidence rows.
  • Use GPSR / general product safety when the facts match the right-side scope, trigger, and evidence rows.
  • Reuse controls only where the comparison rows show the same actor, obligation, timing, and evidence basis.
Section 1

Start with intended purpose and claims

MDR classification and qualification turn on the product's intended purpose. The MDR text requires classification rules to be applied by intended purpose, and technical documentation must identify the device, intended purpose, risk class, and applicable rule. That makes marketing claims, instructions for use, software outputs, clinical claims, and accessories the first boundary checks.

If the product is sold as a wellness, beauty, sports, comfort, or general consumer product, do not assume that the absence of a medical claim ends the analysis. Annex XVI brings listed groups of products without an intended medical purpose into the MDR framework once common specifications apply.

  • Collect public claims, packaging, IFU text, app screens, sales scripts, website copy, and distributor listings before deciding MDR scope.
  • Check whether the product is a medical device, an accessory, a product listed in MDR Annex XVI, or a non-medical consumer product requiring a separate general product-safety review.
  • Record the facts that drove the answer; a later claim change can move the product from a general product-safety review into MDR or Annex XVI work.
Sources for this answer
Regulation (EU) 2017/745 on medical devices
Supports the MDR scope, intended-purpose, classification, technical-documentation, PMS, vigilance, UDI, and EUDAMED side of the boundary check.
MDCG 2023-6 - Demonstration of equivalence for Annex XVI products
Supports the point that listed products without an intended medical purpose can fall into the MDR framework through Annex XVI common specifications.
Recommended next step

Turn the boundary check into a cited scope record

Use the MDR sources, Annex XVI checks, claim review, and post-market routing rule to separate medical-device obligations from general product-safety follow-up.

Research workflow
Open Research Copilot

Answer MDR scope and evidence questions with cited outputs.

Explore next step
Talk to Sorena
Talk through implementation

Review your product claims, Annex XVI status, PMS routing, and source gaps.

Explore next step
Section 2

Use Annex XVI before treating a non-medical product as ordinary GPSR work

Annex XVI is the main trap in an MDR-versus-general-product-safety comparison. A product can lack a medical purpose and still be pulled into MDR-style controls if it belongs to an Annex XVI group covered by common specifications.

MDCG 2023-6 also warns against casually borrowing clinical data from analogous medical devices for non-medical Annex XVI products. For many visitor use cases, that means the safer operational boundary is: qualify first, check Annex XVI second, then decide what remains for general product-safety handling.

  • Check whether the product is a contact lens or eye-contact product, dermal or mucous membrane filler, body-modification implant, equipment used to reduce or remove adipose tissue, skin-treatment equipment, or brain-stimulation equipment in the Annex XVI family.
  • For dual-purpose products, split the medical and non-medical intended purposes and map evidence to the purpose it actually supports.
  • If Annex XVI applies, build MDR evidence instead of relying on a generic consumer-product safety file.
Sources for this answer
MDCG 2023-6 - Demonstration of equivalence for Annex XVI products
Supports the caution that equivalence between a non-medical Annex XVI product and an analogous medical device is generally not straightforward.
Section 3

Keep MDR vigilance separate from general product-safety alerting

For devices in MDR scope, post-market surveillance and vigilance are part of the MDR file. The MDR requires procedures for PMS and vigilance, and the Blue Guide describes medical devices as having a specific vigilance system for serious incidents.

The MDR grounding folder does not include Regulation (EU) 2023/988 text, so this page does not state GPSR notification deadlines, marketplace duties, penalty rules, or Safety Business Gateway details. Treat those as blocked until a GPSR source is available; only use the general product-safety side here as a reminder to check whether a non-MDR product or non-MDR hazard still needs product-safety action.

  • For MDR devices, keep PMS plans, PMCF logic where relevant, complaint handling, serious-incident assessment, field safety corrective action records, and EUDAMED or national-process evidence together.
  • For non-MDR consumer products, open a separate general product-safety assessment instead of filing the issue only in the MDR technical documentation.
  • For mixed portfolios, maintain a routing rule that sends medical-device incidents to MDR vigilance review and non-device consumer-product hazards to a product-safety review.
Sources for this answer
Regulation (EU) 2017/745 on medical devices
Supports MDR-specific PMS, vigilance, technical documentation, and manufacturer evidence expectations.
Commission Notice - Blue Guide on EU product rules (2022)
Supports the cautious general-product-safety fallback and the point that medical devices have a specific vigilance system.
Primary sources

References and citations

European Commission MDR guidance index
health.ec.europa.eu
Referenced sections
  • Supports routing borderline, Annex XVI, PMS, and vigilance questions to MDR-specific guidance materials.
"Manual on borderline and classification"
Regulation (EU) 2023/988 on general product safety
eur-lex.europa.eu
Referenced sections
  • Grounds the GPSR fallback for risks not covered by sector-specific legislation.
"this Regulation applies only to those aspects and risks or categories of risks which are not covered by those requirements"
Related guides

Explore more topics

Custom-made medical devices under the EU MDR | EU MDR FAQ
Concise EU MDR FAQ on custom-made device definition, mass-produced exclusions, Annex XIII statements, documentation, conformity assessment, PMS, vigilance, and records to retain.
EU MDR Annex II and III Technical Documentation
Build an MDR technical documentation index for Annex II device files and Annex III post-market surveillance evidence, including GSPR, risk, clinical, PMS, UDI, and EUDAMED records.
EU MDR Annex VIII Classification Guide
Classify EU MDR medical devices under Annex VIII using intended purpose, duration, invasiveness, active device and software rules, and conformity assessment impact.
EU MDR Annex XVI products without a medical purpose
source-linked EU MDR guide for Annex XVI products: listed product groups, common specifications, clinical evidence, notified-body route, UDI, EUDAMED, PMS, and vigilance evidence before launch.
EU MDR Applicability Test
Test whether a product, accessory, software function, or Annex XVI product falls under the EU Medical Device Regulation, and record the evidence for the next classification step.
EU MDR change assessment workflow
Assess EU MDR device, design, software, intended purpose, QMS, clinical, PMS, UDI, classification, and notified-body impacts before releasing a medical device change.
EU MDR Checklist for Medical Device Compliance
Practical EU MDR checklist covering qualification, classification, conformity assessment, technical documentation, GSPR, clinical evidence, UDI, EUDAMED, PMS, vigilance, QMS, and legacy transition evidence.
EU MDR classification workflow
A concrete EU MDR classification workflow for intended purpose, device or accessory qualification, Annex VIII rule selection, Rule 11 software review, class outcome, and notified body impact.
EU MDR Clinical Evaluation Overview
EU MDR clinical evaluation overview covering Article 61, Annex XIV, clinical data sources, equivalence, PMCF, CER evidence, notified body review, GSPR, and benefit-risk support.
EU MDR Clinical Evaluation Report Template
A source-linked EU MDR clinical evaluation report template covering intended purpose, GSPR linkage, clinical data appraisal, equivalence limits, PMCF, conclusions, and reviewer signoff.
EU MDR clinical evidence guide
source-linked EU MDR guide to clinical evaluation, clinical investigations, equivalence, PMCF, GSPR support, technical documentation, and notified-body review.
EU MDR compliance obligations
EU MDR compliance guide for device qualification, classification, conformity assessment, QMS, technical documentation, UDI, EUDAMED, PMS, vigilance, and legacy transition controls.
EU MDR conformity route workflow
source-linked EU MDR workflow for classifying a device, choosing the conformity assessment route, preparing technical and QMS evidence, and reaching certificate, DoC, UDI, EUDAMED, and CE outputs.
EU MDR deadlines and compliance calendar
Grounded EU MDR calendar for application, legacy-device transition, UDI, EUDAMED, and recurring QMS, technical documentation, clinical, PMS, vigilance, certificate, and change reviews.
EU MDR Device Classification Guide
Classify an EU MDR medical device by intended purpose, Annex VIII duration, invasiveness, active-device and software rules, then document the conformity route impact.
EU MDR EUDAMED and UDI registration
source-linked MDR guide to Basic UDI-DI, UDI-DI, EUDAMED device registration, actor roles, labels, technical documentation, and UDI data governance.
EU MDR FAQ: qualification, evidence, UDI, and transition
Concise EU MDR FAQ covering device qualification, software classification, accessories, custom-made devices, clinical evidence, UDI, EUDAMED, notified bodies, significant changes, and legacy transition.
EU MDR Legacy Device Transition
source-linked EU MDR legacy device transition guide covering Regulation (EU) 2023/607 conditions, certificate validity, significant-change limits, surveillance, PMS, vigilance, QMS, and evidence records.
EU MDR notified body route selection
Choose an EU MDR conformity assessment route by device class, Article 52 option, notified body designation scope, QMS readiness, technical documentation, clinical evidence, and certificate evidence.
EU MDR penalties and enforcement risk
source-linked EU MDR penalties and enforcement-risk guide covering Article 113, Member State penalty rules, market restrictions, recalls, certificate consequences, and evidence.
EU MDR PMS and Vigilance Guide
EU MDR guide to post-market surveillance, PMCF updates, PMS reports, PSURs, serious incident reporting, FSCA/FSN handling, trend reporting, and evidence records.
EU MDR PMS and vigilance records
source-linked EU MDR guide to PMS plans, PMS reports, PSURs, PMCF updates, serious incident and FSCA reporting, trend reporting, and EUDAMED evidence handling.
EU MDR PMS Plan Template for Medical Devices
A source-linked EU MDR post-market surveillance plan template covering device scope, PMS data sources, PMCF linkage, vigilance, trend reporting, PMSR or PSUR outputs, roles, cadence, and evidence records.
EU MDR QMS and technical file evidence map
Map EU MDR Article 10 QMS duties to Annex II and Annex III technical documentation, PMS, vigilance, UDI records, and notified-body review evidence.
EU MDR QMS requirements under Article 10
EU MDR QMS guide for Article 10 manufacturer controls covering regulatory strategy, design, risk, clinical evaluation, PMS, vigilance, UDI, suppliers, CAPA, and conformity records.
EU MDR qualification and borderline products
EU MDR qualification guide for medical purpose claims, accessories, software, Annex XVI products, and borderline routes to classification and conformity assessment.
EU MDR qualification workflow
A concrete EU MDR workflow for deciding whether a product is a medical device, accessory, Annex XVI product, IVD interface, medicinal-product interface, or non-MDR product before classification and conformity assessment.
EU MDR requirements checklist
Concrete EU MDR requirements for medical-device scope, classification, GSPR, conformity assessment, technical documentation, QMS, clinical evidence, UDI, EUDAMED, PMS, vigilance, and economic-operator records.
EU MDR Rule 11 software classification
Classify MDR medical device software under Rule 11 using intended purpose, diagnosis or therapy decision impact, physiological monitoring, conformity route, clinical evidence, and software-change records.
EU MDR significant changes FAQ: legacy-device transition and notified-body review
FAQ on MDR significant changes for legacy devices, including intended-purpose, design, software, material, sterilisation, clinical, QMS, notified-body, and evidence impacts.
EU MDR Transition Timelines: practical guide
EU Medical Device Regulation guide to Transition Timelines with scope decisions, owner actions, evidence records, source-linked citations, and practical next steps.
EU MDR UDI and EUDAMED registration guide
EU MDR guide to Basic UDI-DI, UDI-DI, UDI carriers, EUDAMED actor and device registration, change impacts, and evidence governance.
EU MDR vigilance reporting workflow
Concrete EU MDR vigilance workflow for incident intake, serious incident assessment, FSCA and FSN handling, trend reporting, EUDAMED caveats, CAPA, PMS, clinical evaluation updates, and records.
How should Basic UDI-DI and UDI-DI be assigned under the EU MDR? | EU MDR FAQ
EU MDR FAQ explaining what Basic UDI-DI and UDI-DI identify, how they connect to UDI carriers, EUDAMED records, change triggers, and retained evidence.
MDR vs AI Act for medical-device software
Compare MDR software qualification, classification, clinical evidence, QMS, PMS, UDI, EUDAMED, and notified-body evidence boundaries against cautiously scoped AI Act overlap.
MDR vs IVDR: medical devices and IVDs compared
Compare EU MDR and IVDR scope, classification, conformity routes, technical documentation, clinical or performance evidence, UDI, EUDAMED, PMS, and vigilance.
MDR vs Product Liability Directive evidence comparison
Compare EU MDR market-access evidence with Product Liability Directive exposure without treating compliance records as a liability outcome.
What should an EU MDR PMCF plan and report cover? | EU MDR FAQ
Under the EU MDR, PMCF is part of PMS and clinical evaluation. See what the plan, activities, report, updates, and retained evidence should cover.
What should manufacturers do when an EU MDR classification changes? | EU MDR FAQ
Concise EU MDR FAQ on classification changes, intended purpose, software, notified-body route impact, certificates, technical documentation, and retained evidence.
When can clinical equivalence be used under the EU MDR?
EU MDR FAQ on clinical equivalence, including technical, biological, and clinical characteristics, access to equivalent-device data, class III and implantable-device limits, clinical evaluation, PMCF, and retained evidence.
When do software or products make medical purpose claims under the EU MDR? | EU MDR FAQ
EU MDR FAQ on medical purpose claims, intended purpose evidence, software qualification, Annex XVI contrasts, and records to keep.
When is a PSUR required under the EU MDR and what should it contain? | EU MDR FAQ
EU MDR FAQ on PSUR scope, content, update cadence, PMS and PMCF links, notified-body handling, EUDAMED submission, and evidence to retain.
When is an accessory regulated under the EU MDR? | EU MDR FAQ
EU MDR FAQ on when an article is a medical device accessory, how intended purpose affects classification, and what evidence to keep.
When is software regulated as SaMD under the EU MDR? | EU MDR FAQ
Concise EU MDR FAQ on software qualification, intended medical purpose, Rule 11 classification, modules, clinical evidence, change assessment, UDI, and EUDAMED.
Which devices need an SSCP under the EU MDR and what should it include? | EU MDR FAQ
EU MDR FAQ on when an SSCP is required, who prepares, validates, uploads, and updates it, and what evidence should support the summary.
Which EUDAMED modules matter under the EU MDR? | EU MDR FAQ
EU MDR FAQ mapping EUDAMED modules to actor registration, UDI/device data, certificates, clinical investigations, vigilance/PMS, market surveillance, and practical records.